Bhatti R A, Guinan P D, McKiel C F, Bush I M, Bruns G R, Flanagan M J, Ablin R J
Urology. 1977 Mar;9(3):314-6. doi: 10.1016/0090-4295(77)90357-0.
Preliminary evidence is presented suggestive of antitumor immunity, cross reactive with allogeneic extracts from tumors of the same type, and serum-blocking factor(s), which appear to be specific to autologous tumor only, in patients with prostatic cancer employing the method of leukocyte adherence inhibition.
采用白细胞黏附抑制法对前列腺癌患者进行研究,初步证据表明存在抗肿瘤免疫,该免疫与来自相同类型肿瘤的同种异体提取物具有交叉反应,同时还存在似乎仅对自体肿瘤具有特异性的血清阻断因子。